Mapping of "Long Covid" in patients assisted by the USF Itamarati and previously infected with SARS-CoV-2
DOI:
https://doi.org/10.33448/rsd-v10i15.23536Keywords:
Long Covid; COVID-19; Symptoms; Sequelae.Abstract
Introduction: A fraction of patients with COVID-19 who have gone through a variable acute symptomatic phase of the disease are experiencing ongoing effects of the disease, with complaints such as mental fog, delayed latent periods in remembering events from the recent past, tachycardia, extreme fatigue, disability of performing daily physical tasks, to name a few among a complex array of signs and symptoms. Objective: To estimate and tabulate the main sequelae and symptoms present in patients assisted by the USF Itamarati infected with SARS-CoV-2 during the period between 01/04/2020 and 01/10/2021. Methodology: analytical observational approach developed at the Itamarati Basic Health Unit, located in the Jardim Itamarati neighborhood, in the city of Patos de Minas, Minas Gerais, using data from the Viver Platform, physical records and DATASUS. Results: the prevalence of persistent symptoms was mainly headache, followed by dyspnea, telogen effluvium and fatigue, respectively. In addition, it was found in this study that the mean incidence of these complaints, when associated with the time of positivity for COVID-19, was approximately between 3 and 6 months. Final considerations: the sequelae of COVID-19 can affect the quality of life and even threaten life. Every patient who has been infected with COVID-19 may experience symptoms such as fatigue, shortness of breath, headaches, muscle aches, hair loss, loss of taste and smell, chest pain, dizziness, strokes, palpitations, depression and anxiety , loss of reasoning and memory. Therefore, an individualized assessment by a multidisciplinary team is essential to plan the entire body recovery process and also the monitoring of essential organs, such as the heart, lungs and muscles, to minimize the chances of cardiovascular and thrombotic events in addition to pulmonary sequelae, increased morbidity and poor quality of life due to malnutrition, muscle weakness and pain.
References
Carfi, A., et al. (2020). Sintomas persistentes em pacientes após COVID-19 agudo. JAMA, 324 (6), 603-605.
Greenhalg, T., et al. (2020). Manejo de Covid-19 pós-agudo na atenção primária. The BMJ, 370 (3), 1-9.
Puntmann, V. O., et al. (2020). Resultados da ressonância magnética cardiovascular em pacientes recentemente recuperados da doença coronavírus 2019 (COVID-19). JAMA Cardiology, 28 (5), 78-85.
Rajpal, S., et al. (2020). Achados de ressonância magnética cardiovascular em atletas competitivos em recuperação de infecção por COVID-19. JAMA Cardiology, 31 (6), 1-8.
Rayner, C., et al. (2020). COVID-19: o curso prolongado e recorrente da doença tem implicações para o retorno de trabalhadores. The BMJ, 5 (7), 13-19.
Yelin, D., et al. (2020). Consequências de longo prazo do COVID-19: necessidades de pesquisa. The Lancet Infectious Diseases, 20 (10), 1115-1117.
Zhao, Y. M., et al. (2020). Estudo de acompanhamento da função pulmonar e características fisiológicas relacionadas de sobreviventes de COVID-19 três meses após a recuperação. Clinical Medicine, 25 (6), 63-70.
Zubair, A. S., et al. (2020). Neuropatogênese e manifestações neurológicas dos coronavírus na era da doença coronavírus 2019: uma revisão. JAMA Neurology, 77 (8), 1018-1027.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bárbara Queiroz de Figueiredo; Dalbert Samuel Dutra; Francisca Rafaela Pereira de Anorin Castro Rosa; Iane Andrade Maciel Feldner Cunha; Junio Pereira Marques; Luciana Fernanda Pereira Lopes; Maria Jacilene de Araújo Gomes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
